Fiducial Markers Market In-Depth Analysis, Growth Rate, Future Forecast

Fiducial Markers Market

[146 Pages Report]The Fiducial Markers Market is projected to USD 123 million by 2025 from USD 95 million in 2019, at a CAGR of 4.5% during the forecast period of 2019 to 2025.

According to the new market research report “Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End-user (Hospitals, Outpatient Facilities) – Global Forecast to 2025″, published by MarketsandMarkets™.

Fiducial Markets Market – Global Forecast

Download PDF Brochure:

Market Segmentation in Detailed:

The ultrasound modality segment will register significant growth over the forecast period

On the basis of modality, the market is classified into CT/CBCT, MRI, ultrasound, and radiotherapy. Technological advancements and the rising preference for minimally invasive procedures have supported the high growth of the ultrasound modality segment.

Prostate cancer commanded the leading market share due to the rising preference for radiotherapy treatment

By cancer type, the fiducial markers market is segmented into prostate cancer, lung cancer, breast cancer, gastric cancer, and others. The prostate cancer segment is expected to dominate the market. The ongoing modernization and expansion of healthcare infrastructure, growing medical tourism, and improving research capabilities are expected to improve radiotherapy accessibility, further supporting market growth.

Objectives of the Study in Depth:

  • To define, describe, and forecast the market on the basis of product, cancer type, modality, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the sizes of market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Request Research Sample Pages:

Geographical Analysis in Detailed:

The Asia Pacific is expected to register significant growth over the forecast period owing to the rising patient pool

The Fiducial Markers Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is projected to hold the largest share of the regional market for fiducial markers in 2019. This is attributed to the expansion of the target patient population, favorable reimbursement scenario, greater accessibility to radiotherapy procedures, and the presence of major players in this region.

Key Players in worldwide Industry:

The major players in the market include CIVCO Radiotherapy (US), IZI Medical Products (US), Boston Scientific Corporation (US), Naslund Medical AB (Sweden), and IBA (Belgium). Other players are Best Medical International, Inc. (US), Nanovi A/S (Denmark), Carbon Medical Technologies (US), Eckert & Ziegler (Germany), Innovative Oncology Solutions (US), Medtronic (Ireland), and QFIX (US).

CIVCO Radiotherapy (US): In 2018, CIVCO Radiotherapy (US) dominated the global fiducial markers market in 2019. Its strong product portfolio and high geographic penetration are the key factors contributing to the leading position of this company in the market. In order to maintain its dominant position, the company develops both metal-based as well as polymer-based fiducial markers, such as FusionCoil, PolyMark, FlexiCoil, Align, and PointCoil. The company is also focusing on increasing its presence in developing countries to leverage high-growth opportunities.